<?xml version="1.0" encoding="UTF-8"?>
<p>Similarly, Ivermectin is an anthelmintic drug that acts on parasites and roundworm infections. This drug was shown to be a promising candidate for treating viral diseases, including chikungunya and yellow fever [
 <xref rid="B25-diagnostics-10-00409" ref-type="bibr">25</xref>]. Several clinical trials are underway after Ivermectin was proven to have in vitro activity against SARS-CoV-2. Ivermectin led to significant reduction in viral RNA shortly after treatment [
 <xref rid="B26-diagnostics-10-00409" ref-type="bibr">26</xref>]. However, the concentrations needed to achieve these promising in vitro results were much higher than those recommended and approved for the treatment of parasitic infections. Thereby, the FDA issued a warning against the inappropriate use of Ivermectin for the treatment of COVID-19 patients [
 <xref rid="B27-diagnostics-10-00409" ref-type="bibr">27</xref>].
</p>
